Shibata A - Search Results

1

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.

Kaku K, Takahashi M, Moriyama Y, Nakahata T, Masaoka T, Yoshida Y, Shibata A, Kaneko T, Miwa S. Kaku K, et al. Among authors: shibata a. Leuk Lymphoma. 1993 Oct;11(3-4):229-38. doi: 10.3109/10428199309087000. Leuk Lymphoma. 1993. PMID: 8260897 Clinical Trial.

2

Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. The Multicenter Study Group.

Miwa S, Shibata A, Kaneko T, Moriyama Y, Kaku K, Ishida Y, Takahashi M. Miwa S, et al. Among authors: shibata a. Acta Haematol. 1992;87(1-2):22-8. doi: 10.1159/000204708. Acta Haematol. 1992. PMID: 1585768 Clinical Trial.

3

Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor.

Furukawa T, Takahashi M, Moriyama Y, Koike T, Kurokawa I, Shibata A. Furukawa T, et al. Among authors: shibata a. Ann Hematol. 1991 Feb;62(1):22-4. doi: 10.1007/BF01714979. Ann Hematol. 1991. PMID: 1709572

4

Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.

Takahashi M, Yoshida Y, Kaku K, Masaoka T, Moriyama Y, Nakanishi S, Kaneko T, Shibata A, Miwa S. Takahashi M, et al. Among authors: shibata a. Acta Haematol. 1993;89(4):189-94. doi: 10.1159/000204521. Acta Haematol. 1993. PMID: 8212999 Clinical Trial.

5

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced granulocytopenia in patients with malignancies.

Moriyama Y, Takahashi M, Kaku K, Yoshida Y, Masaoka T, Nakanishi S, Kaneko T, Shibata A, Miwa S. Moriyama Y, et al. Among authors: shibata a. Acta Haematol. 1993;89(2):70-5. doi: 10.1159/000204490. Acta Haematol. 1993. PMID: 8503246 Clinical Trial.

6

Effects of long-term treatment with recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome.

Yoshida Y, Nakahata T, Shibata A, Takahashi M, Moriyama Y, Kaku K, Masaoka T, Kaneko T, Miwa S. Yoshida Y, et al. Among authors: shibata a. Leuk Lymphoma. 1995 Aug;18(5-6):457-63. doi: 10.3109/10428199509059645. Leuk Lymphoma. 1995. PMID: 8528053 Clinical Trial.

7

Gene introduction into granulocyte-macrophage progenitor cells by electroporation: the relationship between introduction efficiency and the proportion of cells in S-phase.

Takahashi M, Furukawa T, Tanaka I, Nikkuni K, Aoki A, Kishi K, Koike T, Moriyama Y, Shibata A. Takahashi M, et al. Among authors: shibata a. Leuk Res. 1992 Aug;16(8):761-7. doi: 10.1016/0145-2126(92)90154-y. Leuk Res. 1992. PMID: 1528064

8

GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol.

Takahashi M, Nikkuni K, Moriyama Y, Shibata A. Takahashi M, et al. Among authors: shibata a. Am J Hematol. 1991 Mar;36(3):213-4. doi: 10.1002/ajh.2830360312. Am J Hematol. 1991. PMID: 1996559

9

Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.

Takahashi M, Aoki A, Mito M, Nikkuni K, Ohtsuka T, Saitoh H, Moriyama Y, Shibata A. Takahashi M, et al. Among authors: shibata a. Hematol Pathol. 1993;7(3):153-8. Hematol Pathol. 1993. PMID: 8244908

10

Effect of pirarubicin for elderly patients with malignant lymphoma.

Aoki S, Tsukada N, Nomoto N, Maruyama S, Takahashi M, Moriyama Y, Shibata A, Aizawa Y. Aoki S, et al. Among authors: shibata a. J Exp Clin Cancer Res. 1998 Dec;17(4):465-70. J Exp Clin Cancer Res. 1998. PMID: 10089069 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,735 results

Search Page

Filters